PAH and phenylketonuria: established an AdV‐mediated PE approach to correct phenylketonuria (PKU) [29], which is caused by a mutation (C‐to‐T conversion) in the Pah gene and induces the deficiency of phenylalanine hydroxylase and the accumulation of excessive phenylalanine in the blood [29, 121].